Shanghai Kindly Clarifies Sales Framework Terms

Shanghai Kindly Medical Instruments Co., Ltd. Class H (HK:1501) has released an update.

Shanghai Kindly Medical Instruments Co., Ltd. has provided additional information regarding its 2025–2027 Sales Framework Agreement, outlining the pricing policy for its medical devices, which will be determined through a public tender process and competitive bidding. The pricing will be in line with market standards and include a reasonable profit margin, ensuring that transactions with its subsidiary KDL are no less favorable than those with independent third parties. The annual caps for the agreement have been set after arm’s length negotiations, based on the transaction history between the Group and KDL.

For further insights into HK:1501 stock, check out TipRanks’ Stock Analysis page.